Call Center: 1-866-766-1485

Cancer Treatment

Cancer specialty procedures

The Cancer centers offer the latest treatment options for cancer patients: stem cell immuno-therapy, surgery, radiation therapy (gamma knife), chemotherapy, gene therapy, traditional Chinese medicine and rehabilitation. China is the only country in the world where gene therapy is licensed (State Food and Drug Administration since 2004).   Stereotactic surgery in combination with oncolytic gene implantation and brain tumor vaccine are two of the most advanced and efficient treatment options available. Our specialists and expert nursing team provide the best medical services to patients from all over the world.

CIK Immunotherapy for Cancer   

"Instead of using surgery, chemotherapy, or radiotherapy, researchers from the National Institutes of Health are finding so-far limited but inspiring success in a new approach for fighting cancer, using the immune system to attack the tumors the way it would be a cold or flu."   - CNN.com (August 2006)

CIK has proved in medical practice to be the most efficiently adopted immunotherapy.  It shows good efficacies in treating malignant tumors in leukemia, melanoma, malignant lymphoma, renal cell carcinoma, metastatic renal carcinoma, lung cancer, liver cancer, breast cancer, ovarian cancer, colon cancer, and gastric cancer.

This treatment can be applied to cancer patients in any stage, and it has good short-term effects for both early stage patients and advanced stage ones. CIK cells eliminate small lesions not available for surgery and tiny cancerous cells scattered in the body to delay or prevent the metastasis or recurrence of tumor. It will have a better efficacy when combined with surgical resection, intervention, radiofrequency therapy, or cryoablation. 

 

WHAT IS IMMUNE CELL THERAPY?
  IMMUNE CELL THERAPY IS THE PROCESS OF USING AUTOLOGOUS IMMUNE CELLS TO TREAT CANCER, HEPATITIS AND OTHER DISEASES, WHICH CANNOT BE EFFECTIVELY TREATED IN OTHER WAYS.

 OUR IMMUNE SYSTEM PLAYS AN EXTREMELY IMPORTANT ROLE WITHIN OUR BODIES. IT IS A COMPLEX SYSTEM OF BIOLOGICAL STRUCTURES, ORGANS AND PROCESSES WITHIN THAT PROTECT US AGAINST DISEASE. TO FUNCTION PROPERLY, OUR IMMUNE SYSTEMS MUST DETECT A WIDE VARIETY OF ADVERSE AGENTS, RANGING FROM VIRUSES TO PARASITIC WORMS, AND DISTINGUISH THEM FROM OUR BODY´S OWN HEALTHY TISSUE.

  IF WE COMPARE THE IMMUNE SYSTEM TO A NATIONAL ARMY, THEN IMMUNE CELLS ARE LIKE SPECIAL FORCES SOLDIERS, EACH DOING THEIR OWN ASSIGNED TASK OF SUPPORTING THE BODY´S NATURAL DEFENSE MECHANISM AND PROTECTING US. AS A RESULT OF THE IMPACT OF EXTERNAL FACTORS IN OUR LIVES, SUCH AS AGING, HIGH STRESS AND PRESSURES, AS WELL AS ENVIRONMENTAL POLLUTION, OUR IMMUNE CELLS ARE NOT ONLY DECLINING BUT THOSE GENERATED ARE OF INCREASINGLY POOR QUALITY. “THE ARMY BECOMES PALE” AND ANY ONE OF OUR TERRIBLE ENEMIES (IE. DISEASES) CAN OVERPOWER US, SUCH AS CANCER FOR EXAMPLE.

 A POPULAR CONCEPT IN THE MEDICAL AREA IS THIS: “ALL CANCER IS SIMPLY THE RESULT OF AN IMMUNE SYSTEM THAT DIDN’T DESTROY MUTANT CELLS”. OBVIOUSLY, CANCER CELLS ARE FOREIGN TO THE BODY AND THE IMMUNE SYSTEM OF A HEALTHY PERSON DESTROYS “10,000” MUTATED (CANCER) CELLS EVERY SINGLE DAY. WHEN THIS DEFENSE CEASES TO FUNCTION PROPERLY, THEN THE CANCER CELLS CAN MULTIPLY AND BECOME A CLINICAL CASE OF CANCER. CONVENTIONAL MEDICAL PRACTICE KNOWS THAT THEIR TREATMENTS OF CHEMOTHERAPY AND RADIATION ARE EQUALLY DEVASTATING TO THE ALREADY WEAKENED IMMUNE SYSTEM; IT IS ACKNOWLEDGED THAT SOME CHEMOTHERAPY AGENTS USED ON PATIENTS WILL ACTUALLY CAUSE OTHER FORMS OF CANCER.

SADLY, LOTS OF CANCER PATIENTS ARE NOT AWARE OF IMMUNE CELL THERAPY, SUCH AS THE GREAT STEVE JOBS WHO RECENTLY DIED OF PANCREATIC CANCER. TODAY, TENS OF THOUSANDS OF CANCER PATIENTS ARE UNDERGOING IMMUNE CELL THERAPY AND RECEIVING THE BENEFITS OF THIS ADVANCED MEDICAL TECHNOLOGY. THE THERAPY HAS BECOME THE NEW DIRECTION FOR CANCER TREATMENT. IN THE FUTURE, MORE AND MORE PATIENTS WILL BENEFIT FROM THIS NEW BIOLOGICALLY BASED ANTI-CANCER TREATMENT.

  SINCE THE 1980S, AS THE FASTEST GROWING AND SAFEST ANTI-TUMOR TREATMENT TECHNOLOGY, BIOLOGICALLY BASED ANTI-CANCER THERAPIES HAVE MADE RAPID SCIENTIFIC DEVELOPMENTS AND MEDICAL BREAKTHROUGHS. IN 2000, ONLY 175 BIOLOGICALLY BASED ANTI-TUMOR L THERAPY CLINICAL TRIALS WERE AMONG THE OVERALL TOTAL OF 369 CLINICAL TRIALS BEING CONDUCTED IN THE U.S. NOW THE
RATIO HAS INCREASED TO MORE THAN 80% BEING IMMUNOCELL THERAPIES. IN 2010, THE FDA FORMALLY APPROVED THE CANCER VACCINE PROVENGE TO TREAT ADVANCED PROSTATE CANCER - A MILESTONE IN THE HISTORY OF ANTI-TUMOR IMMUNOTHERAPY.


  ANTI-CANCER BIOLOGICAL THERAPY HAS NOW BEEN RECOGNIZED AS THE FOURTH MAJOR TREATMENT FOR CANCER IN ADDITION TO SURGERY, RADIATION AND CHEMOTHERAPY. FOR SOME MALIGNANT TUMORS AND ADVANCED CANCERS, IT IS THE PREFERRED TREATMENT FOR PATIENTS.

  TRUEVIEW BIOTECH HAS UPGRADED THIS FIRST GENERATION OF IMMUNOCYTE THERAPEUTIC TECHNOLOGY TO A NEW LEVEL AND STANDARD BY COMBINING THE LATEST TECHNOLOGIES FROM SCIENTIFIC AND MEDICAL RESEARCH. THROUGH COOPERATION WITH FIRST CLASS RESEARCH INSTITUTIONS, TRUEVIEW BIOTECH HAS DEVELOPED SECOND-GENERATION PATENTED TECHNOLOGY, SUCH AS “DIKAT”, “LV-DC-CTL”, AND “γδT”. IN TERMS OF TUMOR ANTIGEN SELECTION, CELL CULTURE TECHNIQUES, AND INDIVIDUALIZED CLINICAL TREATMENT PROGRAMS, THE COMPANY’S TECHNOLOGY HAS SIGNIFICANT ADVANTAGES OVER OTHERS.

  THE IMMUNOTHERAPY PROCESS IS DIVIDED INTO THREE STEPS. FIRSTLY, PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) ARE COLLECTED FROM THE CANCER PATIENT; SECONDLY, THE PBMC ARE ISOLATED AND CULTURED IN VITRO WITHIN A GMP LEVEL STERILE LABORATORY; AND FINALLY, THESE EXPANDED CANCER SENSITIVE CELLS ARE INJECTED BACK TO THE SAME PATIENT THROUGH INTRAVENOUS INFUSION (IV) IN ORDER TO ACTIVATE AND ENHANCE THE PATIENTS´ IMMUNE SYSTEM AGAINST THE CANCER. ADOPTIVE TRANSFER OF ACTIVE IMMUNE CELLS HAS PROVEN TO BE THE MOST EFFECTIVE METHOD OF ELIMINATING SMALL RESIDUAL TUMOR MODULES AND RESTORING NORMAL IMMUNE FUNCTIONS TO CANCER PATIENTS.

Contacts

1-866-766-1485

 Email: info@trueviewbiotech.com

 Skype: stemcelltreatmentcenter